Description: Tilray Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The company offers cannabis-lifestyle and consumer packaged goods; and hemp-based foods and alcoholic beverages. It offers medical cannabis in extracts and dried flower forms; and cannabis extracts, including purified oil drops and capsules. The company supplies cannabis extract products to patients, physicians, pharmacies, hospitals, governments, and researchers. It has operations in Canada, the United States, Europe, Australia, New Zealand, and Latin America. The company was formerly known as Aphria Inc. and changed its name to Tilray, Inc. Tilray Inc. is based in Leamington, Canada.
Home Page: www.tilray.com
TLRY Technical Analysis
265 Talbot Street West
Leamington,
ON
N8H 5L4
Canada
Phone:
844 845 7291
Officers
| Name | Title |
|---|---|
| Mr. Irwin David Simon | Pres, CEO & Chairman |
| Mr. Carl A. Merton CA, CBV, CPA | CFO & Principal Accounting Officer |
| Mr. Mitchell S. Gendel | Global Gen. Counsel & Corp. Sec. |
| Mr. James R. Meiers | Sr. VP of U.S. Operations |
| Ms. Denise Menikheim Faltischek | Chief Strategy Officer & Head of International |
| Mr. Lloyd Brathwaite | Chief Information Officer |
| Mr. Roger Savell | Chief Admin. Officer |
| Mr. John B. Sadler | VP of Investor Relations |
| Ms. Dara S. Redler | Interim Chief Legal Officer & Corp. Sec. |
| Mr. Bernard Yeung | Sr. VP of Sales & Marketing |
Exchange: TO
Country: CA
Currency: Canadian Dollar (C$)
| Forward PE: | 1000 |
|---|---|
| Trailing PE: | 7.1132 |
| Price-to-Book MRQ: | 0.4569 |
| Price-to-Sales TTM: | 4.4144 |
| IPO Date: | |
| Fiscal Year End: | May |
| Full Time Employees: | 1700 |